Niki BioSolutions, Inc. (NIKI) Total Current Liabilities (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Total Current Liabilities came in at $711838.0 in Q4 2025, up 12.06% on a QoQ basis from $635222.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Total Current Liabilities (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Total Current Liabilities data on file, last reported at $711838.0 in Q4 2025.

Quarterly Total Current Liabilities changed N/A year-over-year to $711838.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $711838.0 (changed N/A YoY) and the FY2025 annual result came in at $4.6 million, up 5.87% from the prior year.
Total Current Liabilities grew to $711838.0 in Q4 2025, from $635222.0 in the prior quarter.
In the past five years, Total Current Liabilities ranged from a high of $12.5 million in Q4 2022 to a low of $188826.0 in Q2 2024.
A 5-year average of $3.5 million and a median of $1.8 million in 2023 frame the typical range for Total Current Liabilities.
Annual changes were most pronounced in 2022 — Total Current Liabilities soared 185.64% — and 2023, when it plunged 83.21%.
Tracing NIKI's Total Current Liabilities over 5 years: stood at $4.4 million in 2021, then surged by 185.64% to $12.5 million in 2022, then sank by 83.21% to $2.1 million in 2023, then tumbled by 91.0% to $188826.0 in 2024, then soared by 276.98% to $711838.0 in 2025.
The last three Total Current Liabilities figures came in at $711838.0 (Q4 2025), $635222.0 (Q3 2025), and $317223.0 (Q2 2025), per Business Quant data.

Download Data